Search for a doctor

Vijay Shah, M.D.

  1. Gastroenterologist
  2. Transplant Hepatologist
  3. Chair, Gastroenterology and Hepatology, Minnesota
Request an Appointment

Publications

  1. Kezer CA, Kusztos V, Kassmeyer B, Lennon R, Rattan P, Kamath PS, Shah VH, Simonetto DA. Impact of sociodemographic disparities on sarcopenia, telomere length, and mortality in patients with liver disease in the US population. BMC Gastroenterol. 2024 Nov 11; 24 (1):404
    View PubMed
  2. Bhala N, Shah VH. Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease. Clin Liver Dis. 2024 Nov; 28 (4):819-830 Epub 2024 Aug 14
    View PubMed
  3. Dunn W, Li Y, Singal AK, Simonetto DA, Diaz LA, Idalsoaga F, Ayares G, Arnold J, Ayala-Valverde M, Perez D, Gomez J, Escarate R, Fuentes-Lopez E, Ramirez-Cadiz C, Morales-Arraez D, Zhang W, Qian S, Ahn JC, Buryska S, Mehta H, Dunn N, Waleed M, Stefanescu H, Bumbu A, Horhat A, Attar B, Agrawal R, Cabezas J, Echavaria V, Cuyas B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Higuera-de-la-Tijera F, Kulkarni AV, Rao PN, Guerra-Salazar P, Skladany L, Kubanek N, Prado V, Clemente-Sanchez A, Rincon D, Haider T, Chacko KR, Romero GA, Pollarsky FD, Restrepo JC, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Marciano S, Dirchwolf M, Vargas V, Jimenez C, Hudson D, Garcia-Tsao G, Ortiz G, Abraldes JG, Kamath PS, Arrese M, Shah VH, Bataller R, Arab JP. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study. Hepatology. 2024 Nov 1; 80 (5):1196-1211 Epub 2024 Apr 12
    View PubMed
  4. Islam AH, Diaz LA, Idalsoaga F, Guizzetti L, Mortuza R, Dunn W, Singal AK, Simonetto D, Ramirez-Cadiz C, Zhang W, Qian S, Cabezas J, Sarin SK, Maiwall R, Jalal PK, Higuera-De La Tijera F, Skladany L, Bystrianska N, Rincon D, Chacko KR, Ventura Cots M, Garcia-Tsao G, Abraldes JG, Kamath PS, Arrese M, Shah V, Bataller R, Arab JP. Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis. Hepatol Commun. 2024 Nov 1; 8 (11) Epub 2024 Oct 24
    View PubMed
  5. Xiao J, Wang F, Yuan Y, Gao J, Xiao L, Yan C, Guo F, Zhong J, Che Z, Li W, Lan T, Tacke F, Shah VH, Li C, Wang H, Dong E. Epidemiology of liver diseases: global disease burden and forecasted research trends. Sci China Life Sci. 2024 Oct 16 [Epub ahead of print]
    View PubMed
  6. Ayares G, Diaz LA, Fuentes-Lopez E, Idalsoaga F, Cotter TG, Dunn W, Simonetto D, Shah VH, Kamath PS, Lazarus JV, Bataller R, Arrese M, Wong RJ, Singal AK, Arab JP. Racial and ethnic disparities in the natural history of alcohol-associated liver disease in the United States. Liver Int. 2024 Oct; 44 (10):2822-2833 Epub 2024 Aug 03
    View PubMed
  7. Jophlin LL, Singal AK, Shah VH. Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024 Sep 12 Epub 2024 Sept 12
    View PubMed
  8. Gao J, Lan T, Kostallari E, Guo Y, Lai E, Guillot A, Ding B, Tacke F, Tang C, Shah VH. Angiocrine signaling in sinusoidal homeostasis and liver diseases. J Hepatol. 2024 Sep; 81 (3):543-561 Epub 2024 May 17
    View PubMed
  9. Wang Y, Wang X, Bai B, Shaha A, He X, He Y, Ye Z, Shah VH, Kang N. Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology. 2024 Sep 1; 80 (3):578-594 Epub 2024 Jan 24
    View PubMed
  10. Udompap P, Liu K, Attia IZ, Canning RE, Benson JT, Therneau TM, Noseworthy PA, Friedman PA, Rattan P, Ahn JC, Simonetto DA, Shah VH, Kamath PS, Allen AM. Performance of AI-Enabled Electrocardiogram in the Prediction of Metabolic Dysfunction-Associated Steatotic Liver Disease. Clin Gastroenterol Hepatol. 2024 Aug 27 [Epub ahead of print]
    View PubMed
  11. Ramkissoon R, Cao S, Shah VH. The Pathophysiology of Portal Hypertension. Clin Liver Dis. 2024 Aug; 28 (3):369-381 Epub 2024 Apr 27
    View PubMed
  12. Penrice DD, Hara KS, Sordi-Chara B, Kezer C, Schmidt K, Kassmeyer B, Lennon R, Rosedahl J, Roellinger D, Rattan P, Williams K, Kloft-Nelson S, Leuenberger A, Kamath PS, Shah VH, Simonetto DA. Design, implementation, and impact of a cirrhosis-specific remote patient monitoring program. Hepatol Commun. 2024 Aug 1; 8 (8) Epub 2024 July 22
    View PubMed
  13. Patidar KR, Tu W, Cotter TG, Simonetto DA, Asgharpour A, Jan MY, Tang Q, Yu Y, Li Y, Taiwo M, Thevkar Nagesh P, Dasarathy S, Kamath PS, McClain CJ, Chalasani N, Szabo G, Bataller R, Mitchell M, Mehal WZ, Nagy LE, Shah VH, Gawrieh S, Sanyal AJ, AlcHepNet Investigators. Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology. 2024 Jul 19 Epub 2024 July 19
    View PubMed
  14. Tapper EB, Goldberg D, Parikh ND, Terrault NA, Welch N, Sharpton S, Hameed B, Khalili M, Stolz A, Verna EC, Brown RS Jr, Sanyal AJ, VanWagner L, Ladner DP, Moylan CA, Diehl AM, Jones PD, Loomba R, Dasarathy S, Simonetto DA, Shah VH, Bajaj JS, LCN Study Group. The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. Am J Gastroenterol. 2024 Jul 17 Epub 2024 July 17
    View PubMed
  15. Singal AK, Shah VH, Malhi H. Emerging targets for therapy in ALD: Lessons from NASH. Hepatology. 2024 Jul 1; 80 (1):223-237 Epub 2023 Mar 21
    View PubMed
  16. Chen J, Xu P, Kalutkiewicz K, Sheng Y, Warsame F, Tahboub-Amawi MA, Li J, Wang J, Venkatesh SK, Ehman RL, Shah VH, Simonetto DA, Yin M. Liver stiffness measurement by magnetic resonance elastography predicts cirrhosis and decompensation in alcohol-related liver disease. Abdom Radiol (NY). 2024 Jul; 49 (7):2231-2241 Epub 2024 July 18
    View PubMed
  17. Khanal S, Liu Y, Bamidele AO, Wixom AQ, Washington AM, Jalan-Sakrikar N, Cooper SA, Vuckovic I, Zhang S, Zhong J, Johnson KL, Charlesworth MC, Kim I, Yeon Y, Yoon S, Noh YK, Meroueh C, Timbilla AA, Yaqoob U, Gao J, Kim Y, Lucien F, Huebert RC, Hay N, Simons M, Shah VH, Kostallari E. Glycolysis in hepatic stellate cells coordinates fibrogenic extracellular vesicle release spatially to amplify liver fibrosis. Sci Adv. 2024 Jun 28; 10 (26):eadn5228 Epub 2024 June 28
    View PubMed
  18. Narayanan P, Wu T, Shah VH, Curtis BL. Insights into ALD and AUD diagnosis and prognosis: Exploring AI and multimodal data streams. Hepatology. 2024 May 14 [Epub ahead of print]
    View PubMed
  19. Gan C, Yaqoob U, Lu J, Xie M, Anwar A, Jalan-Sakrikar N, Jerez S, Sehrawat TS, Navarro-Corcuera A, Kostallari E, Habash NW, Cao S, Shah VH. Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV-driven sinusoidal remodeling. JCI Insight. 2024 May 7; 9 (11) Epub 2024 May 07
    View PubMed
  20. Gawrieh S, Dasarathy S, Tu W, Kamath PS, Chalasani NP, McClain CJ, Bataller R, Szabo G, Tang Q, Radaeva S, Barton B, Nagy LE, Shah VH, Sanyal AJ, Mitchell MC, AlcHepNet Investigators. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis. J Hepatol. 2024 May; 80 (5):684-693 Epub 2024 Feb 10
    View PubMed
  21. Sordi Chara B, Hara KS, Penrice D, Schmidt KA, Kassmeyer BA, Anstey J, Tiede D, Kamath PS, Shah VH, Bajaj JS, Kraus A, Simonetto DA. Artificial Intelligence-Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application. Am J Gastroenterol. 2024 May 1; 119 (5):982-986 Epub 2024 Jan 19
    View PubMed
  22. Meroueh C, Warasnhe K, Tizhoosh HR, Shah VH, Ibrahim SH. Digital pathology and spatial omics in steatohepatitis: Clinical applications and discovery potentials. Hepatology. 2024 Mar 22 [Epub ahead of print]
    View PubMed
  23. Guan Y, Peiffer B, Feng D, Parra MA, Wang Y, Fu Y, Shah VH, Cameron AM, Sun Z, Gao B. IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis. J Clin Invest. 2024 Mar 19; 134 (9)
    View PubMed
  24. Diaz LA, Fuentes-Lopez E, Idalsoaga F, Ayares G, Corsi O, Arnold J, Cannistra M, Vio D, Marquez-Lomas A, Ramirez-Cadiz C, Medel MP, Hernandez-Tejero M, Ferreccio C, Lazo M, Roblero JP, Cotter TG, Kulkarni AV, Kim W, Brahmania M, Louvet A, Tapper EB, Dunn W, Simonetto D, Shah VH, Kamath PS, Lazarus JV, Singal AK, Bataller R, Arrese M, Arab JP. Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes. J Hepatol. 2024 Mar; 80 (3):409-418 Epub 2023 Nov 21
    View PubMed
  25. Maheshwari S, Gu CN, Caserta MP, Kezer CA, Shah VH, Torbenson MS, Menias CO, Fidler JL, Venkatesh SK. Imaging of Alcohol-Associated Liver Disease. AJR Am J Roentgenol. 2024 Jan; 222 (1):e2329917 Epub 2023 Sept 20
    View PubMed
  26. Nagesh PT, Cho Y, Zhuang Y, Babuta M, Ortega-Ribera M, Joshi R, Brezani V, Patel A, Datta AA, Brezani V, Hsieh YC, Ramos A, Mehta J, Copeland C, Kanata E, Jiang ZG, Vlachos I, Asara J, Szabo G, Bataller R, McClain CJ, Sanyal A, Mitchell MC, Dasarathy S, Shah VH, Chalasani N, Gawrieh S, Tu W, Barton B. In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating cd84-mediated granulopoiesis. Science Translational Medicine. 2024; 16 (759):eadg1915
  27. Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, Shah VH. ACG Clinical Guideline: Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024 Jan 1; 119 (1):30-54 Epub 2023 Sept 01
    View PubMed
  28. Bhala N, Mellinger J, Asrani SK, Shah VH. Tackling the burden of preventable liver disease in the USA. Lancet Gastroenterol Hepatol. 2024 Jan; 9 (1):9-10 Epub 2023 Nov 11
    View PubMed
  29. Croghan IT, Kumar S, Dugani SB, Hurt RT, Raffals LE, Schletty AA, Schroeder DR, Gathje SR, Shah V. Writing Groups for Healthcare Professionals in Academic Medicine. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241266102
    View PubMed
  30. Wu T, Sherman G, Giorgi S, Thanneeru P, Ungar LH, Kamath PS, Simonetto DA, Curtis BL, Shah VH. Smartphone sensor data estimate alcohol craving in a cohort of patients with alcohol-associated liver disease and alcohol use disorder. Hepatol Commun. 2023 Dec 1; 7 (12) Epub 2023 Dec 07
    View PubMed
  31. Avitabile E, Diaz A, Montironi C, Perez-Guasch M, Gratacos-Gines J, Hernandez-Evole H, Moreira RK, Sehrawat TS, Malhi H, Olivas P, Hernandez-Gea V, Bataller R, Shah VH, Kamath PS, Gines P, Pose E. Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis. Clin Gastroenterol Hepatol. 2023 Nov; 21 (12):3080-3088.e9 Epub 2023 Mar 31
    View PubMed
  32. Avitabile E, Diaz A, Montironi C, Perez-Guasch M, Gratacos-Gines J, Hernandez-Evole H, Moreira RK, Sehrawat TS, Malhi H, Olivas P, Hernandez-Gea V, Bataller R, Shah VH, Kamath PS, Gines P, Pose E. Adding inflammatory markers and refining national institute on alcohol abuse and alcoholism criteria improve diagnostic accuracy for alcohol-associated hepatitis. Clinical Gastroenterology and Hepatology. 2023 Nov; 21 (12):3080-8.e9
  33. Li J, Lu X, Zhu Z, Kalutkiewicz KJ, Mounajjed T, Therneau TM, Venkatesh SK, Sui Y, Glaser KJ, Hoodeshenas S, Manduca A, Shah VH, Ehman RL, Allen AM, Yin M. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH. Hepatology. 2023 Oct 1; 78 (4):1200-1208 Epub 2023 May 01
    View PubMed
  34. Cooper SA, Kostallari E, Shah VH. Angiocrine Signaling in Sinusoidal Health and Disease. Semin Liver Dis. 2023 Aug; 43 (3):245-257 Epub 2023 July 13
    View PubMed
  35. Diaz LA, Fuentes-Lopez E, Ayares G, Idalsoaga F, Arnold J, Valverde MA, Perez D, Gomez J, Escarate R, Villalon A, Ramirez CA, Hernandez-Tejero M, Zhang W, Qian S, Simonetto DA, Ahn JC, Buryska S, Dunn W, Mehta H, Agrawal R, Cabezas J, Garcia-Carrera I, Cuyas B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de-la-Tijera F, Kulkarni AV, Rao PN, Salazar PG, Skladany L, Bystrianska N, Clemente-Sanchez A, Villaseca-Gomez C, Haider T, Chacko KR, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Marciano S, Dirchwolf M, Vargas V, Jimenez C, Louvet A, Garcia-Tsao G, Roblero JP, Abraldes JG, Shah VH, Kamath PS, Arrese M, Singal AK, Bataller R, Arab JP. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis. JHEP Rep. 2023 Aug; 5 (8):100727 Epub 2023 Mar 15
    View PubMed
  36. Kezer CA, Simonetto DA, Shah VH. Acute on Chronic Liver Failure in Patients with Alcohol-Associated Hepatitis: A Review. Clin Liver Dis. 2023 Aug; 27 (3):659-670 Epub 2023 Apr 24
    View PubMed
  37. Malhi H, Shah V, Gores GJ. Thematic reviews: The future of hepatology. Hepatology 2023 Aug 1; 78 (2):388 Epub 2023 Apr 19
    View PubMed
  38. Ahn JC, Wi CI, Buryska S, Sivasubramaniam P, Harmsen WS, Kamath PS, Simonetto DA, Juhn Y, Shah VH. Disproportionate increases in alcohol-associated hepatitis incidence in women and individuals of low socioeconomic status: A population-based study using the Rochester epidemiology project database. Hepatol Commun. 2023 Jun 1; 7 (6) Epub 2023 May 31
    View PubMed
  39. Tu W, Gawrieh S, Dasarathy S, Mitchell MC, Simonetto DA, Patidar KR, McClain CJ, Bataller R, Szabo G, Tang Q, Barton BA, Radaeva S, Sanyal AJ, Shah V, Alcoholic Hepatitis Network (AlcHepNet) Investigators. Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis. Contemp Clin Trials Commun. 2023 Apr; 32:101074 Epub 2023 Jan 18
    View PubMed
  40. Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, Cabezas J, Lozano JJ, Van Booven D, Bell A, Cao S, Vernetti LA, Arab JP, Ventura-Cots M, Edmunds LR, Fondevila C, Starkel P, Dubuquoy L, Louvet A, Odena G, Gomez JL, Aragon T, Altamirano J, Caballeria J, Jurczak MJ, Taylor DL, Berasain C, Wahlestedt C, Monga SP, Morgan MY, Sancho-Bru P, Mathurin P, Furuya S, Lackner C, Rusyn I, Shah VH, Thursz MR, Mann J, Avila MA, Bataller R. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat Commun. 2023 Feb 10; 14 (1):757
    View PubMed
  41. Murad MH, Swift MD, Razonable RR, Tande AJ, Wilson JW, Kasten MJ, Sia IG, Matey JN, Vanichkachorn G, Caine NA, Shah V, O'Horo J, Destro Borgen MJ, Cowl CT, Berbari EF. Integrating Infectious Diseases and Preventive Medicine Specialties Into 1 Division: Experience of an Academic Medical Center. Mayo Clin Proc. 2023 Feb; 98 (2):224-228
    View PubMed
  42. Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, Cabezas J, Lozano JJ, Van Booven D, Bell A, Cao S, Vernetti LA, Arab JP, Ventura-Cots M, Edmunds LR, Fondevila C, Dubuquoy L, Louvet A, Odena G, Gomez JL, Aragon T, Altamirano J, Caballeria J, Jurczak MJ, Taylor DL, Berasain C, Wahlestedt C, Monga SP, Morgan MY, Sancho-Bru P, Mathurin P, Furuya S, Lackner C, Rusyn I, Shah VH, Thursz MR, Mann J, Avila MA, Bataller R. Erratum: Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature communications (2019) 10 1 (3126)). Nature communications. 2023; 14 (1):757
  43. Therneau TM, Mounajjed T, Glaser KJ, Venkatesh SK, Li J, Allen AM, Shah VH, Manduca A, Ehman RL, Yin M, NAFLD MR Imaging Research Group. Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric Surgery. Clin Gastroenterol Hepatol. 2023 Jan; 21 (1):220-222.e3 Epub 2021 Oct 30
    View PubMed
  44. Bataller R, Arab JP, Shah VH. Alcohol-Associated Hepatitis. N Engl J Med. 2022 Dec 29; 387 (26):2436-2448
    View PubMed
  45. Singal AK, DiMartini A, Leggio L, Arab JP, Kuo YF, Shah VH. Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate. Alcohol Alcohol. 2022 Sep 10; 57 (5):576-580
    View PubMed
  46. Greuter T, Yaqoob U, Gan C, Jalan-Sakrikar N, Kostallari E, Lu J, Gao J, Sun L, Liu M, Sehrawat TS, Ibrahim SH, Furuta K, Nozickova K, Huang BQ, Gao B, Simons M, Cao S, Shah VH. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. J Hepatol. 2022 Sep; 77 (3):723-734 Epub 2022 Apr 12
    View PubMed
  47. Ventura-Cots M, Argemi J, Jones PD, Lackner C, El Hag M, Abraldes JG, Alvarado E, Clemente A, Ravi S, Alves A, Alboraie M, Altamirano J, Barace S, Bosques F, Brown R, Caballeria J, Cabezas J, Carvalhana S, Cortez-Pinto H, Costa A, Degre D, Fernandez-Carrillo C, Ganne-Carrie N, Garcia-Tsao G, Genesca J, Koskinas J, Lanthier N, Louvet A, Lozano JJ, Lucey MR, Masson S, Mathurin P, Mendez-Sanchez N, Miquel R, Moreno C, Mounajjed T, Odena G, Kim W, Sancho-Bru P, Warren Sands R, Szafranska J, Verset L, Schnabl B, Sempoux C, Shah V, Shawcross DL, Stauber RE, Straub BK, Verna E, Tiniakos D, Trepo E, Vargas V, Villanueva C, Woosley JT, Ziol M, Mueller S, Starkel P, Bataller R. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. Gut. 2022 Sep; 71 (9):1856-1866 Epub 2022 Jan 06
    View PubMed
  48. Caine NA, Ebbert JO, Raffals LE, Philpot LM, Sundsted KK, Mikhail AE, Issa M, Schletty AA, Shah VH. A 2030 Vision for the Mayo Clinic Department of Medicine. Mayo Clin Proc. 2022 Jul; 97 (7):1232-1236
    View PubMed
  49. Ahn JC, Noh YK, Rattan P, Buryska S, Wu T, Kezer CA, Choi C, Arunachalam SP, Simonetto DA, Shah VH, Kamath PS. Machine Learning Techniques Differentiate Alcohol-Associated Hepatitis From Acute Cholangitis in Patients With Systemic Inflammation and Elevated Liver Enzymes. Mayo Clin Proc. 2022 Jul; 97 (7):1326-1336
    View PubMed
  50. Rattan P, Shah VH. Review article: current and emerging therapies for acute alcohol-associated hepatitis. Aliment Pharmacol Ther. 2022 Jul; 56 (1):28-40 Epub 2022 May 14
    View PubMed
  51. Choi C, Lennon RJ, Choi DH, Serafim LP, Allen AM, Kamath PS, Shah VH, de Moraes AG, Simonetto DA. Relationship Between Body Mass Index and Survival Among Critically Ill Patients With Cirrhosis. J Intensive Care Med. 2022 Jun; 37(6):817-824. Epub 2021 Jul 05.
    View PubMed
  52. Wu T, Cooper SA, Shah VH. Omics and AI advance biomarker discovery for liver disease. Nat Med 2022 Jun; 28 (6):1131-1132
    View PubMed
  53. Szabo G, Thursz M, Shah VH. Therapeutic advances in alcohol-associated hepatitis. J Hepatol. 2022 Jun; 76 (6):1279-1290
    View PubMed
  54. Caine, NA, Ebbert JO, Raffals L, Philpot L, Sundsted K, Mikhail AE, Issa M, Schletty A, Shah VH. Perspective and Controversy: A 2030 Vision for the Mayo Clinic Department of Medicine Mayo Clinic Proceedings. 2022.
  55. Habash NW, Sehrawat TS, Shah VH, Cao S. Epigenetics of alcohol-related liver diseases. JHEP Rep. 2022 May; 4 (5):100466 Epub 2022 Mar 10
    View PubMed
  56. Morales-Arraez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, Atkinson SR, Sarin SK, Kim W, Chavez-Araujo R, Higuera-de la Tijera MF, Singal AK, Shah VH, Kamath PS, Duarte-Rojo A, Charles EA, Vargas V, Jager M, Rautou PE, Rincon D, Zamarripa F, Restrepo-Gutierrez JC, Torre A, Lucey MR, Arab JP, Mathurin P, Louvet A, Garcia-Tsao G, Gonzalez JA, Verna EC, Brown RS Jr, Argemi J, Fernandez-Carrillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study. Am J Gastroenterol. 2022 May 1; 117 (5):818
    View PubMed
  57. Muthiah MD, Smirnova E, Puri P, Chalasani N, Shah VH, Kiani C, Taylor S, Mirshahi F, Sanyal AJ. Development of Alcohol-Associated Hepatitis Is Associated With Specific Changes in Gut-Modified Bile Acids. Hepatol Commun. 2022 May; 6 (5):1073-1089 Epub 2022 Jan 04
    View PubMed
  58. Singal AK, Kwo P, Kwong A, Liangpunsakul S, Louvet A, Mandrekar P, McClain C, Mellinger J, Szabo G, Terrault N, Thursz M, Winder GS, Kim WR, Shah VH. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease. Hepatology. 2022 Apr; 75 (4):1026-1037 Epub 2021 Nov 27
    View PubMed
  59. Navarro-Corcuera A, Sehrawat TS, Jalan-Sakrikar N, Gibbons HR, Pirius NE, Khanal S, Hamdan FH, Aseem SO, Cao S, Banales JM, Kang N, Faubion WA, LaRusso NF, Shah VH, Huebert RC. Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex. J Hepatol. 2022 Apr; 76 (4):921-933 Epub 2021 Dec 23
    View PubMed
  60. Wu T, Simonetto DA, Halamka JD, Shah VH. The digital transformation of hepatology: The patient is logged in. Hepatology. 2022 Mar; 75 (3):724-739 Epub 2022 Jan 31
    View PubMed
  61. Ahn JC, Attia ZI, Rattan P, Mullan AF, Buryska S, Allen AM, Kamath PS, Friedman PA, Shah VH, Noseworthy PA, Simonetto DA. Development of the AI-Cirrhosis-ECG Score: An Electrocardiogram-Based Deep Learning Model in Cirrhosis. Am J Gastroenterol. 2022 Mar 1; 117 (3):424-432
    View PubMed
  62. Kezer CA, Buryska SM, Ahn JC, Harmsen WS, Dunn W, Singal AK, Arab JP, Diaz LA, Arnold J, Kamath PS, Shah VH, Simonetto DA. The Mortality Index for Alcohol-Associated Hepatitis: A Novel Prognostic Score. Mayo Clin Proc. 2022 Mar; 97 (3):480-490 Epub 2022 Feb 15
    View PubMed
  63. Buchl SC, Hanquier Z, Haak AJ, Thomason YM, Huebert RC, Shah VH, Maiers JL. Traf2 and NCK Interacting Kinase Is a Critical Regulator of Procollagen I Trafficking and Hepatic Fibrogenesis in Mice. Hepatol Commun. 2022 Mar; 6 (3):593-609 Epub 2021 Oct 22
    View PubMed
  64. Cui H, Divakaran A, Hoell ZJ, Ellingson MO, Scholtz CR, Zahid H, Johnson JA, Griffith EC, Gee CT, Lee AL, Khanal S, Shi K, Aihara H, Shah VH, Lee RE, Harki DA, Pomerantz WCK. A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes. J Med Chem. 2022 Feb 10; 65 (3):2342-2360 Epub 2022 Jan 10
    View PubMed
  65. Sun L, Wang Y, Wang X, Navarro-Corcuera A, Ilyas S, Jalan-Sakrikar N, Gan C, Tu X, Shi Y, Tu K, Liu Q, Lou Z, Dong H, Sharpe AH, Shah VH, Kang N. PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-beta receptor I versus II. Cell Rep. 2022 Feb 8; 38 (6):110349
    View PubMed
  66. Jones BE, Allegretti AS, Pose E, Mara KC, Ufere NN, Avitabile E, Shah VH, Kamath PS, Gines P, Simonetto DA. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery. Dig Dis Sci. 2022 Feb; 67 (2):697-707 Epub 2021 Feb 19
    View PubMed
  67. Madathanapalli A, Tang Q, Lammert C, Samala N, Shah VH, Sanyal A, Chalasani N, Desai A. Health-related quality of life is dynamic in alcoholic hepatitis and responds to improvement in liver disease and reduced alcohol consumption. Alcohol Clin Exp Res. 2022 Feb; 46 (2):252-261 Epub 2021 Dec 16
    View PubMed
  68. Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, Kamath PS, Mangaonkar AA, Simonetto DA. Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatol Commun. 2022 Feb; 6 (2):399-410 Epub 2021 Aug 28
    View PubMed
  69. Morales-Arraez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, Atkinson SR, Sarin SK, Kim W, Chavez-Araujo R, Higuera-de la Tijera MF, Singal AK, Shah VH, Kamath PS, Duarte-Rojo A, Charles EA, Vargas V, Jager M, Rautou PE, Rincon D, Zamarripa F, Restrepo-Gutierrez JC, Torre A, Lucey MR, Arab JP, Mathurin P, Louvet A, Garcia-Tsao G, Gonzalez JA, Verna EC, Brown RS Jr, Argemi J, Fernandez-Carrillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study. Am J Gastroenterol. 2022 Feb 1; 117 (2):301-310
    View PubMed
  70. Kostallari E, Wei B, Sicard D, Li J, Cooper SA, Gao J, Dehankar M, Li Y, Cao S, Yin M, Tschumperlin DJ, Shah VH. Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2022 Feb 1; 322 (2):G234-G246 Epub 2021 Dec 23
    View PubMed
  71. Jalan-Sakrikar N, De Assuncao TM, Navarro-Corcuera A, Hamdan FH, Loarca L, Kirkeby LA, Resch ZT, O'Hara SP, Juran BD, Lazaridis KN, Rosen CB, Heimbach JK, Taner T, Shah VH, LaRusso NF, Huebert RC. Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation. Hepatol Commun. 2022 Feb; 6 (2):345-360 Epub 2021 Aug 25
    View PubMed
  72. Choi C, Choi DH, Spears GM, Peeraphatdit TB, Serafim LP, Gajic O, Kamath PS, Shah VH, Gallo de Moraes A, Simonetto DA. Relationship Between Etiology of Cirrhosis and Survival Among Patients Hospitalized in Intensive Care Units. Mayo Clin Proc. 2022 Feb; 97(2):274-284. Epub 2022 Jan 25.
    View PubMed
  73. Ramkissoon R, Shah VH. Alcohol Use Disorder and Alcohol-Associated Liver Disease. Alcohol Res. 2022; 42 (1):13 Epub 2022 Nov 10
    View PubMed
  74. Trebicka J, Louvet A, Arroyo V, Jalan R, Shah VH, Moreau R. Severe alcoholic hepatitis as precipitant for organ failure and ACLF. Z Gastroenterol. 2022 Jan; 60 (1):67-76 Epub 2022 Jan 18
    View PubMed
  75. Arab JP, Izzy M, Leggio L, Bataller R, Shah VH. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol. 2022 Jan; 19 (1):45-59 Epub 2021 Nov 01
    View PubMed
  76. Penrice DD, Shah S, Kezer CA, Peeraphatdit TB, Sanyal AJ, Davis B, Mara KC, Shah VH, Kamath PS, Simonetto DA. Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol-Associated Hepatitis. Hepatol Commun. 2021 Dec; 5 (12):2096-2103 Epub 2021 July 28
    View PubMed
  77. Kezer CA, Shah VH, Simonetto DA. Advances in Predictive Modeling Using Machine Learning in the Field of Hepatology. Clin Liver Dis (Hoboken). 2021 Dec; 18 (6):288-291 Epub 2021 Dec 20
    View PubMed
  78. Im GY, Mellinger JL, Winters A, Aby ES, Lominadze Z, Rice J, Lucey MR, Arab JP, Goel A, Jophlin LL, Sherman CB, Parker R, Chen PH, Devuni D, Sidhu S, Dunn W, Szabo G, Singal AK, Shah VH. Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group. Clin Gastroenterol Hepatol. 2021 Nov; 19 (11):2407-2416.e8 Epub 2020 Oct 16
    View PubMed
  79. Yang Z, Zhang T, Kusumanchi P, Tang Q, Sun Z, Radaeva S, Peiffer B, Shah VH, Kamath P, Gores GJ, Sanyal A, Chalasani N, Jiang Y, Huda N, Ma J, Liangpunsakul S. Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis. Hepatology. 2021 Nov; 74 (5):2436-2451 Epub 2021 July 26
    View PubMed
  80. Arab JP, Diaz LA, Baeza N, Idalsoaga F, Fuentes-Lopez E, Arnold J, Ramirez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, Garcia-Carrera I, Parker R, Cuyas B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladany L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincon D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, Garcia-Tsao G, Gonzalez JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol. 2021 Nov; 75 (5):1026-1033 Epub 2021 June 21
    View PubMed
  81. Robinson K, Shah VH. Alcohol-Related Liver Disease. Clin Liver Dis (Hoboken). 2021 Oct; 18 (Suppl 1):93-106 Epub 2021 Oct 29
    View PubMed
  82. Chen J, Martin-Mateos R, Li J, Yin Z, Chen J, Lu X, Glaser KJ, Mounajjed T, Yashiro H, Siegelman J, Winkelmann CT, Wang J, Ehman RL, Shah VH, Yin M. Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease. Alcohol Clin Exp Res. 2021 Oct; 45 (10):2103-2117 Epub 2021 Sept 05
    View PubMed
  83. Shamseddeen H, Madathanapalli A, Are VS, Shah VH, Sanyal AJ, Tang Q, Liang T, Gelow K, Zimmers TA, Chalasani N, Desai AP. Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD. Dig Dis Sci. 2021 Sep; 66 (9):3062-3073 Epub 2020 Oct 19
    View PubMed
  84. Cao S, Liu M, Sehrawat TS, Shah VH. Regulation and functional roles of chemokines in liver diseases. Nat Rev Gastroenterol Hepatol. 2021 Sep; 18 (9):630-647 Epub 2021 May 11
    View PubMed
  85. Singal AK, Arsalan A, Dunn W, Arab JP, Wong RJ, Kuo YF, Kamath PS, Shah VH. Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics. Aliment Pharmacol Ther. 2021 Aug; 54 (4):451-461 Epub 2021 July 11
    View PubMed
  86. Kostallari E, Valainathan S, Biquard L, Shah VH, Rautou PE. Role of extracellular vesicles in liver diseases and their therapeutic potential. Adv Drug Deliv Rev. 2021 Aug; 175:113816 Epub 2021 June 02
    View PubMed
  87. Liu M, Cao S, He L, Gao J, Arab JP, Cui H, Xuan W, Gao Y, Sehrawat TS, Hamdan FH, Ventura-Cots M, Argemi J, Pomerantz WCK, Johnsen SA, Lee JH, Gao F, Ordog T, Mathurin P, Revzin A, Bataller R, Yan H, Shah VH. Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis. Nat Commun. 2021 Jul 27; 12 (1):4560 Epub 2021 July 27
    View PubMed
  88. Shah V, Iwakiri Y, Boyer JL. Obituary for Roberto J. Groszmann - the Father of Portal Hypertension. Hepatology. 2021 Jun 9 Epub 2021 June 09
    View PubMed
  89. Gao J, Wei B, Liu M, Hirsova P, Sehrawat TS, Cao S, Hu X, Xue F, Yaqoob U, Kang N, Cui H, Pomerantz WCK, Kostallari E, Shah VH. Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling. Hepatology. 2021 Jun; 73 (6):2468-2483 Epub 2021 Apr 19
    View PubMed
  90. Ahn JC, Connell A, Simonetto DA, Hughes C, Shah VH. Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases. Hepatology. 2021 Jun; 73 (6):2546-2563
    View PubMed
  91. Asrani SK, Mellinger J, Arab JP, Shah VH. Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action. Hepatology. 2021 May; 73 (5):2039-2050
    View PubMed
  92. Xue F, Lu J, Buchl SC, Sun L, Shah VH, Malhi H, Maiers JL. Coordinated signaling of activating transcription factor 6alpha and inositol-requiring enzyme 1alpha regulates hepatic stellate cell-mediated fibrogenesis in mice. Am J Physiol Gastrointest Liver Physiol. 2021 May 1; 320 (5):G864-G879 Epub 2021 Mar 17
    View PubMed
  93. Li J, Sehrawat TS, Chen J, Hilscher MB, Glaser KJ, Arab JP, De Assuncao TM, Simonetto DA, Mounajjed T, Manduca A, Ehman RL, Shah VH, Yin M. Quantitative assessment of portal hypertension with bi-parametric dual-frequency hepatic MR elastography in mouse models. Eur Radiol. 2021 Apr; 31 (4):2303-2311 Epub 2020 Oct 07
    View PubMed
  94. Yang J, Syed F, Xia Y, Sanyal AJ, Shah VH, Chalasani N, Zheng X, Yu Q, Lou Y, Li W. Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3alpha and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis. Alcohol Clin Exp Res. 2021 Apr; 45 (4):720-731 Epub 2021 Mar 11
    View PubMed
  95. Massey V, Parrish A, Argemi J, Moreno M, Mello A, Garcia-Rocha M, Altamirano J, Odena G, Dubuquoy L, Louvet A, Martinez C, Adrover A, Affo S, Morales-Ibanez O, Sancho-Bru P, Millan C, Alvarado-Tapias E, Morales-Arraez D, Caballeria J, Mann J, Cao S, Sun Z, Shah V, Cameron A, Mathurin P, Snider N, Villanueva C, Morgan TR, Guinovart J, Vadigepalli R, Bataller R. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis. Gastroenterology. 2021 Apr; 160 (5):1725-1740.e2 Epub 2020 Dec 10
    View PubMed
  96. Kezer CA, Simonetto DA, Shah VH. Sex Differences in Alcohol Consumption and Alcohol-Associated Liver Disease. Mayo Clin Proc. 2021 Apr; 96 (4):1006-1016 Epub 2021 Mar 10
    View PubMed
  97. Yohanathan L, Corsini CG, Ramkissoon R, Mousa O, Watt KD, Friedman DZP, Shah VH, Hines AS, Kamath PS, Razonable RR, Badley AD, DeMartino ES, Joyner MJ, Vergidis P, Simonetto DA, Sanchez W, Taner T, Heimbach JK, Beam E, Leise MD. Liver Transplantation for Acute Liver Failure in a Patient with COVID-19 Infection and SARS-CoV-2 PCR Positivity American Journal of Transplantation. 2021.
  98. Beaudoin JJ, Liang T, Tang Q, Banini BA, Shah VH, Sanyal AJ, Chalasani NP, Gawrieh S. Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis. Alcohol Clin Exp Res. 2021 Apr; 45 (4):709-719 Epub 2021 Apr 20
    View PubMed
  99. Furuta K, Guo Q, Pavelko KD, Lee JH, Robertson KD, Nakao Y, Melek J, Shah VH, Hirsova P, Ibrahim SH. Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis. J Clin Invest. 2021 Mar 15; 131 (6)
    View PubMed
  100. Guldiken N, Argemi J, Gurbuz B, Atkinson SR, Oliverius M, Fila P, Hamesch K, Bruns T, Cabezas J, Lozano JJ, Mann J, Cao S, Mathurin P, Shah VH, Trautwein C, Thursz MR, Bataller R, Strnad P. Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases. BMC Med. 2021 Feb 17; 19 (1):39
    View PubMed
  101. Aseem SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, De Assuncao TM, Hamdan FH, Chowdhury S, Banales JM, Johnsen SA, Shah VH, Huebert RC. Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-beta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis. Gastroenterology. 2021 Feb; 160 (3):889-905.e10 Epub 2020 Oct 12
    View PubMed
  102. Sehrawat TS, Arab JP, Liu M, Amrollahi P, Wan M, Fan J, Nakao Y, Pose E, Navarro-Corcuera A, Dasgupta D, Liao CY, He L, Mauer AS, Avitabile E, Ventura-Cots M, Bataller RA, Sanyal AJ, Chalasani NP, Heimbach JK, Watt KD, Gores GJ, Gines P, Kamath PS, Simonetto DA, Hu TY, Shah VH, Malhi H. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Hepatology. 2021 Feb; 73 (2):571-585 Epub 2020 Oct 30
    View PubMed
  103. Ahn JC, Shah VH. Deep learning-based detection of hepatobiliary disorders in ophthalmic imaging. Lancet Digit Health 2021 Feb; 3 (2):e68-e69
    View PubMed
  104. He L, Sehrawat TS, Verma VK, Navarro-Corcuera A, Sidhu G, Mauer A, Luo X, Katsumi T, Chen J, Shah S, Arab JP, Cao S, Kashkar H, Gores GJ, Malhi H, Shah VH. XIAP Knockdown in Alcohol-Associated Liver Disease Models Exhibits Divergent in vitro and in vivo Phenotypes Owing to a Potential Zonal Inhibitory Role of SMAC. Front Physiol. 2021; 12:664222 Epub 2021 May 07
    View PubMed
  105. Peeraphatdit TB, Ahn JC, Choi DH, Allen AM, Simonetto DA, Kamath PS, Shah VH. A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality. Mayo Clin Proc. 2020 Dec; 95 (12):2612-2620
    View PubMed
  106. Gao J, Wei B, de Assuncao TM, Liu Z, Hu X, Ibrahim S, Cooper SA, Cao S, Shah VH, Kostallari E. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J Hepatol. 2020 Nov; 73 (5):1144-1154 Epub 2020 May 08
    View PubMed
  107. Peeraphatdit TB, Nkomo VT, Naksuk N, Simonetto DA, Thakral N, Spears GM, Harmsen WS, Shah VH, Greason KL, Kamath PS. Long-Term Outcomes After Transcatheter and Surgical Aortic Valve Replacement in Patients With Cirrhosis: A Guide for the Hepatologist. Hepatology. 2020 Nov; 72 (5):1735-1746 Epub 2020 Oct 15
    View PubMed
  108. Choi JH, Loarca L, De Hoyos-Vega JM, Dadgar N, Loutherback K, Shah VH, Stybayeva G, Revzin A. Microfluidic confinement enhances phenotype and function of hepatocyte spheroids. Am J Physiol Cell Physiol. 2020 Sep 1; 319 (3):C552-C560 Epub 2020 July 22
    View PubMed
  109. Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int. 2020 Sep; 14 (5):667-676 Epub 2020 Sept 05
    View PubMed
  110. Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology. 2020 Aug; 72 (2):441-453 Epub 2020 Apr 27
    View PubMed
  111. Smirnova E, Puri P, Muthiah MD, Daitya K, Brown R, Chalasani N, Liangpunsakul S, Shah VH, Gelow K, Siddiqui MS, Boyett S, Mirshahi F, Sikaroodi M, Gillevet P, Sanyal AJ. Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity. Hepatology. 2020 Jul; 72 (1):271-286
    View PubMed
  112. Arab JP, Cabrera D, Sehrawat TS, Jalan-Sakrikar N, Verma VK, Simonetto D, Cao S, Yaqoob U, Leon J, Freire M, Vargas JI, De Assuncao TM, Kwon JH, Guo Y, Kostallari E, Cai Q, Kisseleva T, Oh Y, Arrese M, Huebert RC, Shah VH. Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. J Hepatol. 2020 Jul; 73 (1):149-160 Epub 2020 Feb 20
    View PubMed
  113. Hilscher MB, Shah VH. Neutrophil Extracellular Traps and Liver Disease. Semin Liver Dis. 2020 May; 40 (2):171-179 Epub 2019 Nov 14
    View PubMed
  114. Faulkner CS, White CM, Shah VH, Jophlin LL. A single nucleotide polymorphism of PLIN2 is associated with nonalcoholic steatohepatitis and causes phenotypic changes in hepatocyte lipid droplets: A pilot study. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 May; 1865 (5):158637 Epub 2020 Jan 23
    View PubMed
  115. Jophlin LL, Cao S, Shah VH. The Transcriptome of Hepatic Fibrosis Revealed by Single-Cell RNA Sequencing. Hepatology 2020 May; 71 (5):1865-1867
    View PubMed
  116. Xia Y, Yang J, Sanyal AJ, Shah VH, Chalasani NP, Yu Q, Zheng X, Li W. Persistent Hyperactivation of Endothelial Cells in Patients with Alcoholic Hepatitis. Alcohol Clin Exp Res. 2020 May; 44 (5):1075-1087 Epub 2020 Apr 21
    View PubMed
  117. Simonetto DA, Shah VH, Kamath PS. Outpatient management of alcohol-related liver disease. Lancet Gastroenterol Hepatol. 2020 May; 5 (5):485-493
    View PubMed
  118. Sehrawat TS, Liu M, Shah VH. The knowns and unknowns of treatment for alcoholic hepatitis. Lancet Gastroenterol Hepatol. 2020 May; 5 (5):494-506
    View PubMed
  119. Shaheen MF, Joo D, Ross JJ, Anderson BD, Chen HS, Huebert RC, Li Y, Amiot B, Young A, Zlochiver V, Nelson E, Mounajjed T, Dietz AB, Michalak G, Steiner BG, Davidow DS, Paradise CR, van Wijnen AJ, Shah VH, Liu M, Nyberg SL. Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigs. Nat Biomed Eng. 2020 Apr; 4 (4):437-445 Epub 2019 Oct 14
    View PubMed
  120. Shaheen MF, Joo DJ, Ross JJ, Anderson BD, Chen HS, Huebert RC, Li Y, Amiot B, Young A, Zlochiver V, Nelson E, Mounajjed T, Dietz AB, Michalak G, Steiner BG, Davidow DS, Paradise CR, van Wijnen AJ, Shah VH, Liu M, Nyberg SL. Author Correction: Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigs. Nat Biomed Eng. 2020 Apr; 4 (4):476
    View PubMed
  121. Hilscher MB, Shah VH. Small but Mighty: Platelets in NASH and Other Chronic Liver Diseases. Hepatology 2020 Apr; 71 (4):1501-1504 Epub 2020 Mar 18
    View PubMed
  122. Xiang X, Feng D, Hwang S, Ren T, Wang X, Trojnar E, Matyas C, Mo R, Shang D, He Y, Seo W, Shah VH, Pacher P, Xie Q, Gao B. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. J Hepatol. 2020 Apr; 72 (4):736-745 Epub 2019 Nov 29
    View PubMed
  123. Arab JP, Arrese M, Shah VH. Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives. Hepatol Res. 2020 Apr; 50 (4):407-418 Epub 2020 Jan 13
    View PubMed
  124. Li W, Xia Y, Yang J, Guo H, Sun G, Sanyal AJ, Shah VH, Lou Y, Zheng X, Chalasani N, Yu Q. Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis. Hepatol Commun. 2020 Apr; 4 (4):588-605 Epub 2020 Jan 12
    View PubMed
  125. Atkinson SR, Hamesch K, Spivak I, Guldiken N, Cabezas J, Argemi J, Theurl I, Zoller H, Cao S, Mathurin P, Shah VH, Trautwein C, Bataller R, Thursz MR, Strnad P. Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis. Am J Gastroenterol. 2020 Mar; 115 (3):398-405
    View PubMed
  126. Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Schulte PJ, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Chen J, Ehman RL, Yin M. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. Hepatology. 2020 Feb; 71 (2):510-521 Epub 2019 Mar 15
    View PubMed
  127. Peeraphatdit TB, Kamath PS, Karpyak VM, Davis B, Desai V, Liangpunsakul S, Sanyal A, Chalasani N, Shah VH, Simonetto DA. Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2020 Feb; 18 (2):477-485.e5 Epub 2019 Apr 28
    View PubMed
  128. Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Gunneson TJ, Ehman RL, Yin M. Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery. Hepatol Commun. 2020 Feb; 4 (2):185-192 Epub 2019 Nov 05
    View PubMed
  129. Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im G, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transpl. 2020 Jan; 26 (1):127-140
    View PubMed
  130. Singal AK, Arora S, Wong RJ, Satapathy SK, Shah VH, Kuo YF, Kamath PS. Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States. Am J Gastroenterol. 2020 Jan; 115 (1):88-95
    View PubMed
  131. Maddur H, Shah VH. Alcohol and Liver Function in Women. Alcohol Res. 2020; 40 (2):10 Epub 2020 July 02
    View PubMed
  132. Yaqoob U, Luo F, Greuter T, Jalan Sakrikar N, Sehrawat TS, Lu J, Hu X, Gao J, Kostallari E, Chen J, Arab JP, Martin-Mateos R, Cao S, Shah VH. GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a beta1-Integrin Pathway. Cell Mol Gastroenterol Hepatol. 2020; 10 (3):545-559 Epub 2020 May 22
    View PubMed
  133. Robinson KE, Shah VH. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease. Transl Gastroenterol Hepatol. 2020; 5:49 Epub 2020 Oct 05
    View PubMed
  134. Cao Q, Sun X, Rajesh K, Chalasani N, Gelow K, Katz B, Shah VH, Sanyal AJ, Smirnova E. Effects of Rare Microbiome Taxa Filtering on Statistical Analysis. Front Microbiol. 2020; 11:607325 Epub 2021 Jan 12
    View PubMed
  135. Maddur H, Shah VH. The role of nutrition in the pathogenesis and treatment of alcohol-related liver disease. Current Hepatology Reports. 2020; 19 (1):7-12
  136. Mindikoglu AL, Coarfa C, Opekun AR, Shah VH, Arab JP, Lazaridis KN, Putluri N, Ambati CR, Robertson MJ, Devaraj S, Jalal PK, Rana A, Goss JA, Dowling TC, Weir MR, Seliger SL, Raufman JP, Bernard DW, Vierling JM. Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Future Sci OA. 2019 Dec 17; 6 (2):FSO441
    View PubMed
  137. Jalan-Sakrikar N, De Assuncao TM, Shi G, Aseem S, Chi C, Shah VH, Huebert RC. Proteasomal Degradation of Enhancer of Zeste Homologue 2 in Cholangiocytes Promotes Biliary Fibrosis. Hepatology. 2019 Nov; 70 (5):1674-1689 Epub 2019 June 22
    View PubMed
  138. Garg SK, Sarvepalli S, Singh D, Obaitan I, Peeraphatdit T, Jophlin L, Asrani SK, Shah VH, Leise MD. Incidence and Risk Factors Associated With 30-Day Readmission for Alcoholic Hepatitis. J Clin Gastroenterol. 2019 Nov/Dec; 53 (10):759-764
    View PubMed
  139. Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Diaz Espinosa AM, Aravamudhan A, Maiers JL, Britt RD Jr, Roden AC, Pabelick CM, Prakash YS, Nouraie SM, Li X, Zhang Y, Kass DJ, Lagares D, Tager AM, Varelas X, Shah VH, Tschumperlin DJ. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. Sci Transl Med. 2019 Oct 30; 11 (516)
    View PubMed
  140. Wang Y, Tu K, Liu D, Guo L, Chen Y, Li Q, Maiers JL, Liu Z, Shah VH, Dou C, Tschumperlin D, Voneschen L, Yang R, Kang N. p300 Acetyltransferase Is a Cytoplasm-to-Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor beta-Stimulated Hepatic Stellate Cells. Hepatology. 2019 Oct; 70 (4):1409-1423 Epub 2019 May 23
    View PubMed
  141. Sunjaya DB, Lennon RJ, Shah VH, Kamath PS, Simonetto DA. Prevalence and Predictors of Third-Generation Cephalosporin Resistance in the Empirical Treatment of Spontaneous Bacterial Peritonitis. Mayo Clin Proc. 2019 Aug; 94 (8):1499-1508 Epub 2019 July 11
    View PubMed
  142. Shah VH, Shah PP. How to Use Emotional Intelligence as a Career Catalyst- the X-Factor of Success for Trainees and Faculty in Gastroenterology and Hepatology. Gastroenterology. 2019 Aug; 157 (2):289-292 Epub 2019 May 11
    View PubMed
  143. Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, Cabezas J, Lozano JJ, Van Booven D, Bell A, Cao S, Vernetti LA, Arab JP, Ventura-Cots M, Edmunds LR, Fondevila C, Starkel P, Dubuquoy L, Louvet A, Odena G, Gomez JL, Aragon T, Altamirano J, Caballeria J, Jurczak MJ, Taylor DL, Berasain C, Wahlestedt C, Monga SP, Morgan MY, Sancho-Bru P, Mathurin P, Furuya S, Lackner C, Rusyn I, Shah VH, Thursz MR, Mann J, Avila MA, Bataller R. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat Commun. 2019 Jul 16; 10 (1):3126 Epub 2019 July 16
    View PubMed
  144. Hilscher MB, Sehrawat T, Arab Verdugo JP, Arab JP, Zeng Z, Gao J, Liu M, Kostallari E, Gao Y, Simonetto DA, Yaqoob U, Cao S, Revzin A, Beyder A, Wang RA, Kamath PS, Kubes P, Shah VH. Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension. Gastroenterology. 2019 Jul; 157 (1):193-209.e9 Epub 2019 Mar 11
    View PubMed
  145. Samala N, Gawrieh S, Tang Q, Lourens SG, Shah VH, Sanyal AJ, Liangpunsakul S, Chalasani N. Clinical Characteristics and Outcomes of Mild to Moderate Alcoholic Hepatitis. GastroHep. 2019 Jul; 1 (4):161-165 Epub 2019 June 14
    View PubMed
  146. Li W, Lin EL, Liangpunsakul S, Lan J, Chalasani S, Rane S, Puri P, Kamath PS, Sanyal AJ, Shah VH, Radaeva S, Crabb DW, Chalasani N, Yu Q. Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis. Clin Transl Gastroenterol. 2019 Jun; 10 (6):e00052
    View PubMed
  147. Eguchi A, Kostallari E, Feldstein AE, Shah VH. Extracellular vesicles, the liquid biopsy of the future. J Hepatol. 2019 Jun; 70 (6):1292-1294 Epub 2019 Apr 12
    View PubMed
  148. Liu M, Shah VH. New Prospects for Medical Management of Acute Alcoholic Hepatitis. Clin Liver Dis (Hoboken). 2019 May; 13 (5):131-135 Epub 2019 May 31
    View PubMed
  149. Szabo G, Kamath PS, Shah VH, Thursz M, Mathurin P, EASL-AASLD Joint Meeting. Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study. Hepatology. 2019 May; 69 (5):2271-2283 Epub 2019 Jan 15
    View PubMed
  150. Arab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera-De la Tijera F, Restrepo JC, Torre A, Urzua A, Simonetto DA, Abraldes JG, Mendez-Sanchez N, Contreras F, Lucey MR, Shah VH, Cortez-Pinto H, Bataller R. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol. 2019 May - Jun; 18 (3):518-535 Epub 2019 Apr 18
    View PubMed
  151. Wang L, Feng Y, Xie X, Wu H, Su XN, Qi J, Xin W, Gao L, Zhang Y, Shah VH, Zhu Q. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells. EBioMedicine. 2019 May; 43:525-536 Epub 2019 May 03
    View PubMed
  152. Sharma M, Singh S, Desai V, Shah VH, Kamath PS, Murad MH, Simonetto DA. Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta-analysis. Hepatology. 2019 Apr; 69 (4):1657-1675 Epub 2019 Feb 20
    View PubMed
  153. Thursz M, Kamath PS, Mathurin P, Szabo G, Shah VH. Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study. J Hepatol. 2019 Mar; 70 (3):521-530 Epub 2019 Jan 15
    View PubMed
  154. Liu Z, Li C, Kang N, Malhi H, Shah VH, Maiers JL. Transforming growth factor beta (TGFbeta) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation. J Biol Chem. 2019 Mar 1; 294 (9):3137-3151 Epub 2019 Jan 04
    View PubMed
  155. Abraldes JG, Trebicka J, Chalasani N, D'Amico G, Rockey DC, Shah VH, Bosch J, Garcia-Tsao G. Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension. Hepatology. 2019 Mar; 69 (3):1287-1299 Epub 2019 Feb 09
    View PubMed
  156. Singal AK, Shah VH. Current trials and novel therapeutic targets for alcoholic hepatitis. J Hepatol. 2019 Feb; 70 (2):305-313
    View PubMed
  157. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. Response to Forrest et al. Am J Gastroenterol 2019 Jan; 114 (1):176
    View PubMed
  158. Greuter T, Shah VH. Too Stiff, Too Late . . . Timing Is Everything in Antiangiogenic Treatment of Liver Fibrosis. Hepatology. 2019 Jan; 69 (1):449-451 Epub 2018 Dec 18
    View PubMed
  159. Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G, Mathurin P, Urrutia R, Huebert RC, Shah VH. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-beta Dependent Hepatic Stellate Cell Activation and Liver Fibrosis. Cell Mol Gastroenterol Hepatol. 2019; 7 (1):197-209 Epub 2018 Sept 15
    View PubMed
  160. Kamath PS, Shah VH. Alcohol-related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study. Hepatology. 2018 Dec 18 [Epub ahead of print]
    View PubMed
  161. Sujan R, Cruz-Lemini M, Altamirano J, Simonetto DA, Maiwall R, Axley P, Richardson T, Desai V, Cabezas J, Vargas V, Kamath PS, Shah VH, Sarin SK, Bataller R, Singal AK. A Validated Score Predicts Acute Kidney Injury and Survival in Patients With Alcoholic Hepatitis. Liver Transpl. 2018 Dec; 24 (12):1655-1664
    View PubMed
  162. Jophlin LL, Koutalos Y, Chen C, Shah V, Rockey DC. Hepatic stellate cells retain retinoid-laden lipid droplets after cellular transdifferentiation into activated myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1; 315 (5):G713-G721 Epub 2018 July 19
    View PubMed
  163. Samala N, Lourens SG, Shah VH, Kamath PS, Sanyal AJ, Crabb DW, Tang Q, Radaeva S, Liangpunsakul S, Chalasani N. Posttraumatic Stress Disorder in Patients with Heavy Alcohol Consumption and Alcoholic Hepatitis. Alcohol Clin Exp Res. 2018 Oct; 42 (10):1933-1938 Epub 2018 Aug 26
    View PubMed
  164. Singal AK, Louvet A, Shah VH, Kamath PS. Grand Rounds: Alcoholic Hepatitis. J Hepatol. 2018 Aug; 69 (2):534-543 Epub 2018 June 13
    View PubMed
  165. Kostallari E, Hirsova P, Prasnicka A, Verma VK, Yaqoob U, Wongjarupong N, Roberts LR, Shah VH. Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2. Hepatology. 2018 Jul; 68 (1):333-348 Epub 2018 May 10
    View PubMed
  166. Kolla BP, Schneekloth TD, Biernacka J, Shah V, Lazaridis KN, Geske J, Karpyak V. PNPLA3 Association with Alcoholic Liver Disease in a Cohort of Heavy Drinkers. Alcohol Alcohol. 2018 Jul 1; 53 (4):357-360
    View PubMed
  167. Dou C, Liu Z, Tu K, Zhang H, Chen C, Yaqoob U, Wang Y, Wen J, van Deursen J, Sicard D, Tschumperlin D, Zou H, Huang WC, Urrutia R, Shah VH, Kang N. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts. Gastroenterology. 2018 Jun; 154 (8):2209-2221.e14 Epub 2018 Feb 15
    View PubMed
  168. Sunjaya DB, Ramos GP, Braga Neto MB, Lennon R, Mounajjed T, Shah V, Kamath PS, Simonetto DA. Isolated hepatic non-obstructive sinusoidal dilatation, 20-year single center experience. World J Hepatol. 2018 May 27; 10 (5):417-424
    View PubMed
  169. Puri P, Liangpunsakul S, Christensen JE, Shah VH, Kamath PS, Gores GJ, Walker S, Comerford M, Katz B, Borst A, Yu Q, Kumar DP, Mirshahi F, Radaeva S, Chalasani NP, Crabb DW, Sanyal AJ, TREAT Consortium. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. Hepatology. 2018 Apr; 67 (4):1284-1302 Epub 2018 Feb 22
    View PubMed
  170. Arab JP, Martin-Mateos RM, Shah VH. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatol Int. 2018 Feb; 12 (Suppl 1):24-33 Epub 2017 May 26
    View PubMed
  171. Chirapongsathorn S, Krittanawong C, Enders FT, Pendegraft R, Mara KC, Borah BJ, Visscher SL, Loftus CG, Shah VH, Talwalkar JA, Kamath PS. Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis. Hepatol Commun. 2018 Feb; 2 (2):188-198 Epub 2018 Jan 18
    View PubMed
  172. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018 Feb; 113 (2):175-194 Epub 2018 Jan 16
    View PubMed
  173. Sherman KE, Shah VH. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia. Gastroenterology. 2018 Feb; 154 (3):453-456 Epub 2017 Nov 14
    View PubMed
  174. Tschumperlin DJ, Ligresti G, Hilscher MB, Shah VH. Mechanosensing and fibrosis. J Clin Invest. 2018 Jan 2; 128 (1):74-84 Epub 2018 Jan 02
    View PubMed
  175. Liangpunsakul S, Beaudoin JJ, Shah VH, Puri P, Sanyal AJ, Kamath PS, Lourens SG, Tang Q, Katz BP, Crabb DW, Chalasani NP. Interaction between the patatin-like phospholipase domain-containing protein 3 genotype and coffee drinking and the risk for acute alcoholic hepatitis. Hepatol Commun. 2018 Jan; 2 (1):29-34 Epub 2017 Nov 11
    View PubMed
  176. Drinane MC, Yaqoob U, Yu H, Luo F, Greuter T, Arab JP, Kostallari E, Verma VK, Maiers J, De Assuncao TM, Simons M, Mukhopadhyay D, Kisseleva T, Brenner DA, Urrutia R, Lomberk G, Gao Y, Ligresti G, Tschumperlin DJ, Revzin A, Cao S, Shah VH. Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms. JCI Insight. 2017 Dec 21; 2 (24)
    View PubMed
  177. Comerford M, Lourens S, Liangpunsakul S, Chalasani NP, Sanyal AJ, Shah VH, Kamath PS, Puri P, Katz BP, Radaeva S, Crabb DW. Challenges in Patient Enrollment and Retention in Clinical Studies for Alcoholic Hepatitis: Experience of the TREAT Consortium. Alcohol Clin Exp Res. 2017 Dec; 41 (12):2000-2006 Epub 2017 Oct 27
    View PubMed
  178. Beaudoin JJ, Long N, Liangpunsakul S, Puri P, Kamath PS, Shah V, Sanyal AJ, Crabb DW, Chalasani NP, Urban TJ, TREAT Consortium. An exploratory genome-wide analysis of genetic risk for alcoholic hepatitis. Scand J Gastroenterol. 2017 Nov; 52 (11):1263-1269 Epub 2017 Aug 04
    View PubMed
  179. Simonetto DA, Kamath PS, Shah VH. Alcoholic hepatitis: Continued drinking and the mourning after. Hepatology 2017 Nov; 66 (5):1370-1372 Epub 2017 Oct 11
    View PubMed
  180. Greuter T, Malhi H, Gores GJ, Shah VH. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight. 2017 Sep 7; 2 (17) Epub 2017 Sept 07
    View PubMed
  181. Yin M, Glaser KJ, Manduca A, Mounajjed T, Malhi H, Simonetto DA, Wang R, Yang L, Mao SA, Glorioso JM, Elgilani FM, Ward CJ, Harris PC, Nyberg SL, Shah VH, Ehman RL. Distinguishing between Hepatic Inflammation and Fibrosis with MR Elastography. Radiology. 2017 Sep; 284 (3):694-705 Epub 2017 Jan 27
    View PubMed
  182. Vargas JI, Arrese M, Shah VH, Arab JP. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects. Curr Gastroenterol Rep. 2017 Sep; 19 (9):43
    View PubMed
  183. Liu Y, Verma VK, Malhi H, Gores GJ, Kamath PS, Sanyal A, Chalasani N, Gao B, Shah VH. Lipopolysaccharide downregulates macrophage-derived IL-22 to modulate alcohol-induced hepatocyte cell death. Am J Physiol Cell Physiol. 2017 Sep 1; 313 (3):C305-C313 Epub 2017 June 21
    View PubMed
  184. Li W, Amet T, Xing Y, Yang D, Liangpunsakul S, Puri P, Kamath PS, Sanyal AJ, Shah VH, Katz BP, Radaeva S, Crabb DW, Chalasani N, Yu Q. Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational study. Hepatology. 2017 Aug; 66 (2):575-590 Epub 2017 June 30
    View PubMed
  185. Lourens S, Sunjaya DB, Singal A, Liangpunsakul S, Puri P, Sanyal A, Ren X, Gores GJ, Radaeva S, Chalasani N, Crabb DW, Katz B, Kamath PS, Shah VH, TREAT Consortium. Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective Study. Mayo Clin Proc Innov Qual Outcomes. 2017 Jul; 1 (1):37-48 Epub 2017 Apr 28
    View PubMed
  186. Mauer AS, Hirsova P, Maiers JL, Shah VH, Malhi H. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1; 312 (3):G300-G313 Epub 2016 Dec 30
    View PubMed
  187. Maiers JL, Kostallari E, Mushref M, deAssuncao TM, Li H, Jalan-Sakrikar N, Huebert RC, Cao S, Malhi H, Shah VH. The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice. Hepatology. 2017 Mar; 65 (3):983-998 Epub 2016 Dec 31
    View PubMed
  188. Chen G, Nakamura I, Dhanasekaran R, Iguchi E, Tolosa EJ, Romecin PA, Vera RE, Almada LL, Miamen AG, Chaiteerakij R, Zhou M, Asiedu MK, Moser CD, Han S, Hu C, Banini BA, Oseini AM, Chen Y, Fang Y, Yang D, Shaleh HM, Wang S, Wu D, Song T, Lee JS, Thorgeirsson SS, Chevet E, Shah VH, Fernandez-Zapico ME, Roberts LR. Transcriptional Induction of Periostin by a Sulfatase 2-TGFbeta1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma. Cancer Res. 2017 Feb 1; 77 (3):632-645 Epub 2016 Nov 21
    View PubMed
  189. Wang R, Ding Q, De Assuncao TM, Mounajjed T, Maiers JL, Dou C, Cao S, Yaqoob U, Huebert RC, Shah VH. Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. Am J Pathol. 2017 Jan; 187 (1):134-145 Epub 2016 Nov 10
    View PubMed
  190. Russ KB, Chen NW, Kamath PS, Shah VH, Kuo YF, Singal AK. Reply to ''Alcohol and Liver Transplantation''. Alcohol Alcohol. 2017 Jan; 52 (1):127 Epub 2016 Sept 05
    View PubMed
  191. Hirsova P, Ibrahim SH, Verma VK, Morton LA, Shah VH, LaRusso NF, Gores GJ, Malhi H. Extracellular vesicles in liver pathobiology: Small particles with big impact. Hepatology. 2016 Dec; 64 (6):2219-2233 Epub 2016 Oct 20
    View PubMed
  192. Liangpunsakul S, Puri P, Shah VH, Kamath P, Sanyal A, Urban T, Ren X, Katz B, Radaeva S, Chalasani N, Crabb DW, Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Effects of Age, Sex, Body Weight, and Quantity of Alcohol Consumption on Occurrence and Severity of Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2016 Dec; 14 (12):1831-1838.e3 Epub 2016 June 15
    View PubMed
  193. Russ KB, Chen NW, Kamath PS, Shah VH, Kuo YF, Singal AK. Alcohol Use after Liver Transplantation is Independent of Liver Disease Etiology. Alcohol Alcohol. 2016 Nov; 51 (6):698-701 Epub 2016 June 06
    View PubMed
  194. Allen JI, Wang TC, Cohen WS, Shah VH. How to Succeed in Academic Gastroenterology. Gastroenterology. 2016 Oct; 151 (4):578-581.e6 Epub 2016 Aug 27
    View PubMed
  195. Cuervo H, Nielsen CM, Simonetto DA, Ferrell L, Shah VH, Wang RA. Endothelial notch signaling is essential to prevent hepatic vascular malformations in mice. Hepatology. 2016 Oct; 64 (4):1302-1316 Epub 2016 Aug 04
    View PubMed
  196. Marrone G, Shah VH, Gracia-Sancho J. Sinusoidal communication in liver fibrosis and regeneration. J Hepatol. 2016 Sep; 65 (3):608-17 Epub 2016 May 02
    View PubMed
  197. Dunn W, Shah VH. Pathogenesis of Alcoholic Liver Disease. Clin Liver Dis. 2016 Aug; 20 (3):445-56 Epub 2016 Mar 28
    View PubMed
  198. Kostallari E, Shah VH. Angiocrine signaling in the hepatic sinusoids in health and disease. Am J Physiol Gastrointest Liver Physiol. 2016 Aug 1; 311 (2):G246-51 Epub 2016 June 10
    View PubMed
  199. Baig MS, Yaqoob U, Cao S, Saqib U, Shah VH. Non-canonical role of matrix metalloprotease (MMP) in activation and migration of hepatic stellate cells (HSCs). Life Sci. 2016 Jun 15; 155:155-60 Epub 2016 Apr 29
    View PubMed
  200. Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH. Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes. Gastroenterology. 2016 Jun; 150 (8):1756-68 Epub 2016 Feb 23
    View PubMed
  201. Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016 Jun; 51 (6):511-9 Epub 2016 Mar 03
    View PubMed
  202. Arab JP, Shah VH. Statins and portal hypertension: A tale of two models. Hepatology. 2016 Jun; 63 (6):2044-7
    View PubMed
  203. Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, Charlton MR, Shah VH, Malhi H, Gores GJ. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. Gastroenterology. 2016 Apr; 150 (4):956-67 Epub 2016 Jan 05
    View PubMed
  204. Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, Cao S, Contreras PC, Malhi H, Kamath PS, Gores GJ, Shah VH. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. 2016 Mar; 64 (3):651-60 Epub 2015 Nov 26
    View PubMed
  205. Shah VH, Gores GJ, LaRusso NF. Hail to the chief-Keith Lindor, our new AASLD president. Hepatology. 2016 Feb; 63 (2):357-9 Epub 2015 Dec 18
    View PubMed
  206. Singal AK, Shah VH. Therapeutic Strategies for the Treatment of Alcoholic Hepatitis. Semin Liver Dis. 2016 Feb; 36: (1)56-68.
    View PubMed
  207. Wang R, Ding Q, Yaqoob U, de Assuncao TM, Verma VK, Hirsova P, Cao S, Mukhopadhyay D, Huebert RC, Shah VH. Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration. J Biol Chem. 2015 Dec 25; 290 (52):30684-96 Epub 2015 Nov 03
    View PubMed
  208. Mushref M, Shah VH. Getting a NOTCH-up on Macrophage Activation in Alcoholic Liver Disease. Gastroenterology 2015 Dec; 149 (7):1979-80 Epub 2015 Oct 20
    View PubMed
  209. Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology. 2015 Oct; 149 (4):958-70.e12 Epub 2015 June 16
    View PubMed
  210. Shah VH. Managing alcoholic liver disease. Clin Mol Hepatol. 2015 Sep; 21 (3):212-9 Epub 2015 Sept 30
    View PubMed
  211. Gao B, Shah VH. Combination therapy: New hope for alcoholic hepatitis? Clin Res Hepatol Gastroenterol. 2015 Sep; 39 Suppl 1 (Suppl 1):S7-S11 Epub 2015 July 17
    View PubMed
  212. Wang Y, Cao Y, Yamada S, Thirunavukkarasu M, Nin V, Joshi M, Rishi MT, Bhattacharya S, Camacho-Pereira J, Sharma AK, Shameer K, Kocher JP, Sanchez JA, Wang E, Hoeppner LH, Dutta SK, Leof EB, Shah V, Claffey KP, Chini EN, Simons M, Terzic A, Maulik N, Mukhopadhyay D. Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-alpha Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1alpha and Mitochondrial Homeostasis. Arterioscler Thromb Vasc Biol. 2015 Jun; 35 (6):1401-12 Epub 2015 Apr 16
    View PubMed
  213. Kang N, Shah VH, Urrutia R. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? Mol Cancer Res. 2015 Apr; 13 (4):604-12 Epub 2014 Dec 29
    View PubMed
  214. Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol. 2015 Apr; 62 (1 Suppl):S121-30
    View PubMed
  215. Giugliano S, Kriss M, Golden-Mason L, Dobrinskikh E, Stone AE, Soto-Gutierrez A, Mitchell A, Khetani SR, Yamane D, Stoddard M, Li H, Shaw GM, Edwards MG, Lemon SM, Gale M Jr, Shah VH, Rosen HR. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology. 2015 Feb; 148 (2):392-402.e13 Epub 2014 Nov 04
    View PubMed
  216. Simonetto DA, Yang HY, Yin M, de Assuncao TM, Kwon JH, Hilscher M, Pan S, Yang L, Bi Y, Beyder A, Cao S, Simari RD, Ehman R, Kamath PS, Shah VH. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces. Hepatology. 2015 Feb; 61 (2):648-59 Epub 2015 Jan 05
    View PubMed
  217. Urrunaga NH, Jadeja RN, Rachakonda V, Ahmad D, McLean LP, Cheng K, Shah V, Twaddell WS, Raufman JP, Khurana S. M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury. Free Radic Biol Med. 2015 Jan; 78:66-81 Epub 2014 Oct 31
    View PubMed
  218. Tu K, Li J, Verma VK, Liu C, Billadeau DD, Lamprecht G, Xiang X, Guo L, Dhanasekaran R, Roberts LR, Shah VH, Kang N. Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors. Hepatology. 2015 Jan; 61 (1):361-74 Epub 2014 Sept 19
    View PubMed
  219. Liu C, Li J, Xiang X, Guo L, Tu K, Liu Q, Shah VH, Kang N. PDGF receptor-a promotes TGF-ß signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-ß receptors. Am J Physiol Gastrointest Liver Physiol. 2014 Oct 01; 307(7):G749-59. Epub 2014 Aug 28.
    View PubMed
  220. Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol. 2014 Oct; 61 (4):912-24 Epub 2014 June 06
    View PubMed
  221. Bi Y, Li J, Ji B, Kang N, Yang L, Simonetto DA, Kwon JH, Kamath M, Cao S, Shah V. Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth. Am J Pathol. 2014 Oct; 184 (10):2791-802 Epub 2014 Aug 08
    View PubMed
  222. Bi Y, Mukhopadhyay D, Drinane M, Ji B, Li X, Cao S, Shah VH. Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics. Am J Physiol Cell Physiol. 2014 Oct 1; 307 (7):C622-33 Epub 2014 July 30
    View PubMed
  223. Geng ZM, Li QH, Li WZ, Zheng JB, Shah V. Activated human hepatic stellate cells promote growth of human hepatocellular carcinoma in a subcutaneous xenograft nude mouse model. Cell Biochem Biophys. 2014 Sep; 70(1):337-47.
    View PubMed
  224. Mehta G, Gustot T, Mookerjee RP, Garcia-Pagan JC, Fallon MB, Shah VH, Moreau R, Jalan R. Inflammation and portal hypertension - the undiscovered country. J Hepatol. 2014 Jul; 61 (1):155-63 Epub 2014 Mar 18
    View PubMed
  225. de Assuncao TM, Lomberk G, Cao S, Yaqoob U, Mathison A, Simonetto DA, Huebert RC, Urrutia RA, Shah VH. New role for Kruppel-like factor 14 as a transcriptional activator involved in the generation of signaling lipids. J Biol Chem. 2014 May 30; 289 (22):15798-809 Epub 2014 Apr 23
    View PubMed
  226. Simonetto DA, Shah VH, Kamath PS. Primary prophylaxis of esophageal varices. Clinics in Liver Disease.2014;18:(2)335-45.
  227. Simonetto DA, Shah VH, Kamath PS. Primary prophylaxis of variceal bleeding. Clin Liver Dis. 2014 May; 18 (2):335-45 Epub 2014 Feb 25
    View PubMed
  228. Asrani SK, Talwalkar JA, Kamath PS, Shah VH, Saracino G, Jennings L, Gross JB, Venkatesh S, Ehman RL. Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol. 2014 May; 60 (5):934-9 Epub 2013 Dec 19
    View PubMed
  229. Altamirano J, Miquel R, Katoonizadeh A, Abraldes JG, Duarte-Rojo A, Louvet A, Augustin S, Mookerjee RP, Michelena J, Smyrk TC, Buob D, Leteurtre E, Rincon D, Ruiz P, Garcia-Pagan JC, Guerrero-Marquez C, Jones PD, Barritt AS 4th, Arroyo V, Bruguera M, Banares R, Gines P, Caballeria J, Roskams T, Nevens F, Jalan R, Mathurin P, Shah VH, Bataller R. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014 May; 146 (5):1231-9.e1-6 Epub 2014 Jan 15
    View PubMed
  230. Yang L, Kwon J, Popov Y, Gajdos GB, Ordog T, Brekken RA, Mukhopadhyay D, Schuppan D, Bi Y, Simonetto D, Shah VH. Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology. 2014 May; 146 (5):1339-50.e1 Epub 2014 Feb 04
    View PubMed
  231. Singal AK, Kamath PS, Gores GJ, Shah VH. Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol. 2014 Apr; 12 (4):555-64; quiz e31-2 Epub 2013 June 28
    View PubMed
  232. Granzow M, Schierwagen R, Klein S, Kowallick B, Huss S, Linhart M, Mazar IGR, Gortzen J, Vogt A, Schildberg FA, Gonzalez-Carmona MA, Wojtalla A, Kramer B, Nattermann J, Siegmund SV, Werner N, Fürst DO, Laleman W, Knolle P, Shah VH, Sauerbruch T, Trebicka J. Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis. Hepatology. 2014; 60(1):334-48.
    View PubMed
  233. Joshi HP, Subramanian IV, Schnettler EK, Ghosh G, Rupaimoole R, Evans C, Saluja M, Jing Y, Cristina I, Roy S, Zeng Y, Shah VH, Sood AK, Ramakrishnan S. Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis. Proc Natl Acad Sci U S A. 2014; 111(14):5331-6.
    View PubMed
  234. Yaqoob U, Jagavelu K, Shergill U, de Assuncao T, Cao S, Shah VH. FGF21 promotes endothelial cell angiogenesis through a dynamin-2 and Rab5 dependent pathway. PLoS One. 2014; 9 (5):e98130 Epub 2014 May 21
    View PubMed
  235. Seo YS, Kwon JH, Yaqoob U, Yang L, De Assuncao TM, Simonetto DA, Verma VK, Shah VH. HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury. Am J Physiol Gastrointest Liver Physiol. 2013 Dec; 305 (11):G838-48 Epub 2013 Oct 03
    View PubMed
  236. Singal AK, Kamath PS, Francisco Ziller N, DiCecco S, Shoreibah M, Kremers W, Charlton MR, Heimbach JK, Watt KD, Shah VH. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int. 2013 Aug; 26 (8):788-94 Epub 2013 June 11
    View PubMed
  237. Bi Y, Venkatesh SK, Shah VH. Detecting fibrosis without a liver biopsy: getting to the fat of the issue. Hepatol Int. 2013 Jul; 7 (3):792-4 Epub 2013 July 18
    View PubMed
  238. Drinane MC, Shah VH. Alcoholic hepatitis: Diagnosis and prognosis. Clin Liver Dis (Hoboken). 2013 Apr; 2 (2):80-83 Epub 2013 Apr 24
    View PubMed
  239. Liu C, Billadeau DD, Abdelhakim H, Leof E, Kaibuchi K, Bernabeu C, Bloom GS, Yang L, Boardman L, Shah VH, Kang N. IQGAP1 suppresses TbetaRII-mediated myofibroblastic activation and metastatic growth in liver. J Clin Invest. 2013 Mar; 123 (3):1138-56 Epub 2013 Feb 01
    View PubMed
  240. Mathison A, Grzenda A, Lomberk G, Velez G, Buttar N, Tietz P, Hendrickson H, Liebl A, Xiong YY, Gores G, Fernandez-Zapico M, Larusso NF, Faubion W, Shah VH, Urrutia R. Role for Kruppel-like transcription factor 11 in mesenchymal cell function and fibrosis. PLoS One. 2013; 8 (9):e75311 Epub 2013 Sept 17
    View PubMed
  241. Seo YS, Shah VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol. 2012 Dec; 18 (4):337-46 Epub 2012 Dec 21
    View PubMed
  242. Simonetto DA, Shah VH. Primary prophylaxis of esophageal variceal bleeding. Clin Liver Dis (Hoboken). 2012 Nov; 1 (5):147-150 Epub 2012 Nov 09
    View PubMed
  243. Yaqoob U, Cao S, Shergill U, Jagavelu K, Geng Z, Yin M, de Assuncao TM, Cao Y, Szabolcs A, Thorgeirsson S, Schwartz M, Yang JD, Schwartz M, Ehman R, Roberts L, Mukhopadhyay D, Shah VH. Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Res. 2012 Aug 15; 72 (16):4047-59 Epub 2012 June 27
    View PubMed
  244. Zhu Q, Zou L, Jagavelu K, Simonetto DA, Huebert RC, Jiang ZD, DuPont HL, Shah VH. Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol. 2012 Apr; 56 (4):893-9 Epub 2011 Dec 13
    View PubMed
  245. Zou L, Cao S, Kang N, Huebert RC, Shah VH. Fibronectin induces endothelial cell migration through beta1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766. J Biol Chem. 2012 Mar 2; 287 (10):7190-202 Epub 2012 Jan 14
    View PubMed
  246. Sethi S, Simonetto DA, Abdelmoneim SS, Campion MB, Kaloiani I, Clayton AC, Kremers WK, Halling KC, Kamath PS, Talwalkar J, Shah VH. Comparison of circulating endothelial cell/platelet count ratio to aspartate transaminase/platelet ratio index for identifying patients with cirrhosis. J Clin Exp Hepatol. 2012 Mar; 2 (1):19-26 Epub 2012 Apr 12
    View PubMed
  247. Huebert RC, Jagavelu K, Hendrickson HI, Vasdev MM, Arab JP, Splinter PL, Trussoni CE, Larusso NF, Shah VH. Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs. Am J Pathol. 2011 Oct; 179 (4):1851-60 Epub 2011 Aug 18
    View PubMed
  248. Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am. 2011 Sep; 40(3):611-39.
    View PubMed
  249. Seo YS, Shah VH. Pathophysiology of portal hypertension and its clinical links. J Clin Exp Hepatol. 2011 Sep; 1 (2):87-93 Epub 2011 Nov 09
    View PubMed
  250. Thabut D, Routray C, Lomberk G, Shergill U, Glaser K, Huebert R, Patel L, Masyuk T, Blechacz B, Vercnocke A, Ritman E, Ehman R, Urrutia R, Shah V. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology. 2011 Aug; 54 (2):573-85 Epub 2011 June 26
    View PubMed
  251. Kang N, Gores GJ, Shah VH. Hepatic stellate cells: partners in crime for liver metastases? Hepatology. 2011 Aug; 54 (2):707-13
    View PubMed
  252. Routray C, Liu C, Yaqoob U, Billadeau DD, Bloch KD, Kaibuchi K, Shah VH, Kang N. Protein kinase G signaling disrupts Rac1-dependent focal adhesion assembly in liver specific pericytes. Am J Physiol Cell Physiol. 2011 Jul; 301(1):C66-74. Epub 2011 Mar 30.
    View PubMed
  253. Khan JA, Kudgus RA, Szabolcs A, Dutta S, Wang E, Cao S, Curran GL, Shah V, Curley S, Mukhopadhyay D, Robertson JD, Bhattacharya R, Mukherjee P. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One. 2011; 6 (6):e20347 Epub 2011 June 27
    View PubMed
  254. Vaa BE, Asrani SK, Dunn W, Kamath PS, Shah VH. Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc. 2011 Jan; 86 (1):37-42
    View PubMed
  255. Zhang C, Thabut D, Kamath PS, Shah VH. Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding. Liver Int. 2011 Jan; 31(1):108-19. Epub 2010 Oct 14.
    View PubMed
  256. Pereira A, Witek RP, Syn WK, Choi SS, Bradrick S, Karaca GF, Agboola KM, Jung Y, Omenetti A, Moylan CA, Yang L, Fernandez-Zapico ME, Jhaveri R, Shah VH, Pereira FE, Diehl AM. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. Lab Invest. 2010 Dec; 90 (12):1690-703 Epub 2010 Aug 09
    View PubMed
  257. Huebert RC, Jagavelu K, Liebl AF, Huang BQ, Splinter PL, LaRusso NF, Urrutia RA, Shah VH. Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis. Lab Invest. 2010 Dec; 90 (12):1770-81 Epub 2010 July 19
    View PubMed
  258. Costales P, Aledo R, Vernia S, Das A, Shah VH, Casado M, Badimon L, Llorente-Cortes V. Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression. Atherosclerosis. 2010 Dec; 213(2):458-68. Epub 2010 Oct 08.
    View PubMed
  259. Thabut D, Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol. 2010 Nov; 53 (5):976-80 Epub 2010 July 24
    View PubMed
  260. Cao Y, Szabolcs A, Dutta SK, Yaqoob U, Jagavelu K, Wang L, Leof EB, Urrutia RA, Shah VH, Mukhopadhyay D. Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J Biol Chem. 2010 Oct 8; 285 (41):31840-8 Epub 2010 July 30
    View PubMed
  261. Kang N, Yaqoob U, Geng Z, Bloch K, Liu C, Gomez T, Billadeau D, Shah V. Focal adhesion assembly in myofibroblasts fosters a microenvironment that promotes tumor growth. Am J Pathol. 2010 Oct; 177(4):1888-900. Epub 2010 Aug 27.
    View PubMed
  262. Jiang JX, Venugopal S, Serizawa N, Chen X, Scott F, Li Y, Adamson R, Devaraj S, Shah V, Gershwin ME, Friedman SL, Torok NJ. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology. 2010 Oct; 139(4):1375-84. Epub 2010 Jun 01.
    View PubMed
  263. Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, Kim WR. Alcoholic liver disease-related mortality in the United States: 1980-2003. Am J Gastroenterol. 2010 Aug; 105 (8):1782-7 Epub 2010 Feb 23
    View PubMed
  264. Jagavelu K, Routray C, Shergill U, O'Hara SP, Faubion W, Shah VH. Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver. Hepatology. 2010 Aug; 52 (2):590-601
    View PubMed
  265. Das A, Mukherjee P, Singla SK, Guturu P, Frost MC, Mukhopadhyay D, Shah VH, Patra CR. Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide. Nanotechnology. 2010 Jul 30; 21 (30):305102 Epub 2010 July 08
    View PubMed
  266. Huebert RC, Vasdev MM, Shergill U, Das A, Huang BQ, Charlton MR, LaRusso NF, Shah VH. Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis. Hepatology. 2010 Jul; 52 (1):238-48
    View PubMed
  267. Cao S, Yaqoob U, Das A, Shergill U, Jagavelu K, Huebert RC, Routray C, Abdelmoneim S, Vasdev M, Leof E, Charlton M, Watts RJ, Mukhopadhyay D, Shah VH. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 2010 Jul; 120 (7):2379-94 Epub 2010 June 23
    View PubMed
  268. Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. Am J Physiol Gastrointest Liver Physiol. 2010 Jun; 298 (6):G908-15 Epub 2010 Mar 25
    View PubMed
  269. Shah VH. Alcoholic liver disease: the buzz may be gone, but the hangover remains. Hepatology. 2010 May; 51(5):1483-4.
    View PubMed
  270. Shergill U, Das A, Langer D, Adluri R, Maulik N, Shah VH. Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration. Am J Physiol Regul Integr Comp Physiol. 2010 May; 298 (5):R1279-87
    View PubMed
  271. Abdelmoneim SS, Talwalkar J, Sethi S, Kamath P, Fathalla MM, Kipp BR, Campion MB, Clayton AC, Halling KC, Shah VH. A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension. Liver Int. 2010 Feb; 30 (2):191-7 Epub 2009 Oct 19
    View PubMed
  272. Roberts KE, Kawut SM, Krowka MJ, Brown RS, Trotter JF, Shah V, Peter I, Tighiouart H, Mitra N, Handorf E, Knowles JA, Zacks S, Fallon MB. Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology. 2010; 139(1).
  273. Mathison A, Liebl A, Bharucha J, Mukhopadhyay D, Lomberk G, Shah V, Urrutia R. Pancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes. Pancreatology. 2010; 10 (4):505-16 Epub 2010 Sept 16
    View PubMed
  274. Patra CR, Abdel Moneim SS, Wang E, Dutta S, Patra S, Eshed M, Mukherjee P, Gedanken A, Shah VH, Mukhopadhyay D. In vivo toxicity studies of europium hydroxide nanorods in mice. Toxicol Appl Pharmacol. 2009 Oct 1; 240 (1):88-98 Epub 2009 July 17
    View PubMed
  275. Guturu P, Shah V. New insights into the pathobiology of portal hypertension. Hepatol Res. 2009 Oct; 39(10):1016-9.
    View PubMed
  276. Akazawa Y, Mott JL, Bronk SF, Werneburg NW, Kahraman A, Guicciardi ME, Meng XW, Kohno S, Shah VH, Kaufmann SH, McNiven MA, Gores GJ. Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology. 2009 Jun; 136 (7):2365-2376.e1-7 Epub 2009 Mar 09
    View PubMed
  277. Das A, Yaqoob U, Mehta D, Shah VH. FXR promotes endothelial cell motility through coordinated regulation of FAK and MMP-9. Arterioscler Thromb Vasc Biol. 2009 Apr; 29 (4):562-70 Epub 2009 Jan 15
    View PubMed
  278. Guturu P, Shah V, Urrutia R. Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implications. J Gastrointest Cancer. 2009; 40 (1-2):1-9 Epub 2009 June 10
    View PubMed
  279. Vaa Brianna E, Shah VH. Alcoholic Liver Disease—An Update. US Gastroenterology & Hepatology. 2009; 5:44-48.
  280. Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, Boardman L, Gores GJ, Harmsen WS, McClain CJ, Kamath PS, Shah VH. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology. 2008 Dec; 135 (6):1953-60 Epub 2008 Sept 13
    View PubMed
  281. Jiang JX, Mikami K, Shah VH, Torok NJ. Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism. Hepatology. 2008 Nov; 48(5):1497-505.
    View PubMed
  282. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM, Pulmonary Vascular Complications of Liver Disease Study Group. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 Oct; 135(4):1168-75. Epub 2008 Jun 20.
    View PubMed
  283. Decker NK, Abdelmoneim SS, Yaqoob U, Hendrickson H, Hormes J, Bentley M, Pitot H, Urrutia R, Gores GJ, Shah VH. Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver. Am J Pathol. 2008 Oct; 173 (4):1002-12 Epub 2008 Aug 28
    View PubMed
  284. Semela D, Das A, Langer D, Kang N, Leof E, Shah V. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function. Gastroenterology. 2008 Aug; 135 (2):671-9 Epub 2008 Apr 16
    View PubMed
  285. Langer DA, Das A, Semela D, Kang-Decker N, Hendrickson H, Bronk SF, Katusic ZS, Gores GJ, Shah VH. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology. 2008 Jun; 47 (6):1983-93
    View PubMed
  286. Perri RE, Shah VH. Pentoxifylline: not just for alcoholic hepatitis anymore? Hepatol Int. 2008 Jun; 2(2):137-9. Epub 2008 Apr 08.
    View PubMed
  287. Iwakiri Y, Grisham M, Shah V. Vascular biology and pathobiology of the liver: Report of a single-topic symposium. Hepatology. 2008 May; 47(5):1754-63.
    View PubMed
  288. Distrutti E, Mencarelli A, Santucci L, Renga B, Orlandi S, Donini A, Shah V, Fiorucci S. The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology. 2008 Feb; 47(2):659-67.
    View PubMed
  289. Patra CR, Cao S, Safgren S, Bhattacharya R, Ames MM, Shah V, Reid JM. Intracellular fate of a targeted delivery system. J. Biomed. Nanotechnol. 2008; 4(4):508-14.
  290. Shah V. Molecular mechanisms of increased intrahepatic resistance in portal hypertension. J Clin Gastroenterol. 2007 Nov-Dec; 41(10 Suppl 3):S259-61.
    View PubMed
  291. Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, Erdjument-Bromage H, Shah V, Gratton JP, McNally EM, Tempst P, Sessa WC. Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. J Biol Chem. 2007 Oct 19; 282(42):30745-53. Epub 2007 Aug 16.
    View PubMed
  292. Lee JS, Semela D, Iredale J, Shah VH. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology. 2007 Mar; 45(3):817-25.
    View PubMed
  293. Kang-Decker N, Cao S, Chatterjee S, Yao J, Egan LJ, Semela D, Mukhopadhyay D, Shah V. Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. J Cell Sci. 2007 Feb 1; 120 (Pt 3):492-501
    View PubMed
  294. Iwakiri Y, Satoh A, Chatterjee S, Toomre DK, Chalouni CM, Fulton D, Groszmann RJ, Shah VH, Sessa WC. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc Natl Acad Sci U S A. 2006 Dec 26; 103(52):19777-82. Epub 2006 Dec 14.
    View PubMed
  295. Das A, Fernandez-Zapico ME, Cao S, Yao J, Fiorucci S, Hebbel RP, Urrutia R, Shah VH. Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J Biol Chem. 2006 Dec 22; 281 (51):39105-13 Epub 2006 Oct 27
    View PubMed
  296. Trushina E, Singh RD, Dyer RB, Cao S, Shah VH, Parton RG, Pagano RE, McMurray CT. Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet. 2006 Dec 15; 15 (24):3578-91
    View PubMed
  297. Dunn W, Angulo P, Sanderson S, Jamil LH, Stadheim L, Rosen C, Malinchoc M, Kamath PS, Shah VH. Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology. 2006 Oct; 131 (4):1057-63 Epub 2006 Aug 10
    View PubMed
  298. Wang XL, Lu T, Cao S, Shah VH, Lee HC. Inhibition of ATP binding to the carboxyl terminus of Kir6.2 by epoxyeicosatrienoic acids. Biochim Biophys Acta. 2006 Sep; 1761 (9):1041-9 Epub 2006 July 08
    View PubMed
  299. Shah VH, Kamath P. Management of portal hypertension. Postgrad Med. 2006 Sep-Oct; 119 (3):14-8
    View PubMed
  300. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene. 2006 Aug 17; 25(36):4986-97. Epub 2006 Mar 27.
    View PubMed
  301. Semela D, Langer DA, Shah V. GRK2 makes trouble: a no-NO in portal hypertension. Gastroenterology. 2006 Mar; 130(3):1001-3; discussion 1003.
    View PubMed
  302. Perri RE, Langer DA, Chatterjee S, Gibbons SJ, Gadgil J, Cao S, Farrugia G, Shah VH. Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation. Am J Physiol Gastrointest Liver Physiol. 2006 Mar; 290: (3)G535-42.
    View PubMed
  303. Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology. 2006 Feb; 43 (2):335-44
    View PubMed
  304. Langer DA, Shah VH. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis. J Hepatol. 2006 Jan; 44(1):209-16. Epub 2005 Nov 04.
    View PubMed
  305. Billadeau DD, Chatterjee S, Bramati P, Sreekumar R, Shah V, Hedin K, Urrutia R. Characterization of the CXCR4 signaling in pancreatic cancer cells. Int J Gastrointest Cancer. 2006; 37 (4):110-9
    View PubMed
  306. Bhattacharya R, Kang-Decker N, Hughes DA, Mukherjee P, Shah V, McNiven MA, Mukhopadhyay D. Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J. 2005 Oct; 19(12):1692-4. Epub 2005 Jul 27.
    View PubMed
  307. Fiorucci S, Antonelli E, Mencarelli A, Orlandi S, Renga B, Rizzo G, Distrutti E, Shah V, Morelli A. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology. 2005 Sep; 42(3):539-48.
    View PubMed
  308. Lee JS, Kang Decker N, Chatterjee S, Yao J, Friedman S, Shah V. Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol. 2005 Jun; 166 (6):1861-70
    View PubMed
  309. Kamath PS, Shah V. Does nadolol improve the efficacy of endoscopic variceal ligation in the treatment of variceal bleeding? Nat Clin Pract Gastroenterol Hepatol. 2005 Jun; 2(6):254-5.
    View PubMed
  310. Wang XL, Ye D, Peterson TE, Cao S, Shah VH, Katusic ZS, Sieck GC, Lee HC. Caveolae targeting and regulation of large conductance Ca(2+)-activated K+ channels in vascular endothelial cells. J Biol Chem. 2005 Mar 25; 280 (12):11656-64 Epub 2005 Jan 23
    View PubMed
  311. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005 Feb; 41 (2):353-8
    View PubMed
  312. Cao S, Fernandez-Zapico ME, Jin D, Puri V, Cook TA, Lerman LO, Zhu XY, Urrutia R, Shah V. KLF11-mediated repression antagonizes Sp1/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. J Biol Chem. 2005 Jan 21; 280 (3):1901-10 Epub 2004 Nov 05
    View PubMed
  313. Lim I, Gibbons SJ, Lyford GL, Miller SM, Strege PR, Sarr MG, Chatterjee S, Szurszewski JH, Shah VH, Farrugia G. Carbon monoxide activates human intestinal smooth muscle L-type Ca2+ channels through a nitric oxide-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2005 Jan; 288(1):G7-14. Epub 2004 Aug 19.
    View PubMed
  314. Shah V. Molecular mechanisms in the pathogenesis of cirrhotic portal hypertension: focus on nitric oxide. J Gastroenterol Hepatol. 2004 Dec; 19(s7):S145-S149.
    View PubMed
  315. Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome. Liver Transpl. 2004 Apr; 10 (4):480-7
    View PubMed
  316. Shah V, Lyford G, Gores G, Gores G, Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology. 2004 Mar; 126 (3):903-13
    View PubMed
  317. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004 Feb 05; 350: (6)578-85.
    View PubMed
  318. Menon KV, Menon KV, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, Shah V. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol. 2004 Feb; 99 (2):255-60
    View PubMed
  319. Dunn W, Lerman A, Shah V. Clinical expression of endothelial dysfunction. Heart Metabolism. 2004; 22:11-16.
  320. Rockey DC, Shah V. Nitric oxide biology and the liver: Report of an AASLD Research Workshop. Hepatology. 2004 Jan; 39(1):250-7.
    View PubMed
  321. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, Simari RD. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res. 2003 Nov 28; 93 (11):1023-5 Epub 2003 Nov 06
    View PubMed
  322. Chatterjee S, Cao S, Peterson TE, Simari RD, Shah V. Inhibition of GTP-dependent vesicle trafficking impairs internalization of plasmalemmal eNOS and cellular nitric oxide production. J Cell Sci. 2003 Sep 1; 116(Pt 17):3645-55. Epub 2003 Jul 22.
    View PubMed
  323. Hendrickson H, Chatterjee S, Cao S, Morales Ruiz M, Sessa WC, Shah V. Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver. Am J Physiol Gastrointest Liver Physiol. 2003 Sep; 285(3):G652-60. Epub 2003 Jun 26.
    View PubMed
  324. Cao S, Yao J, Shah V. The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function. J Biol Chem. 2003 Feb 21; 278 (8):5894-901 Epub 2002 Dec 16
    View PubMed
  325. Shah V, Kamath PS. Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl. 2003 Jan; 9(1):1-11.
    View PubMed
  326. Shah V, Kamath PS. Portal hypertension: a clinical update in the pathogenesis and treatment of variceal hemorrhage and hepatic encephalopathy. Medscape Gastroenterology. 2003.
  327. Hassoun Z, Shah V, Shah V, Petrovic LM. The choice of calcineurin inhibitor does not influence centrilobular necrosis after orthotopic liver transplantation. Transplant Proc. 2002 Aug; 34 (5):1519-20
    View PubMed
  328. Shah VH, Kamath PS. New developments in portal hypertensive bleeding. Clinical Perspectives in Gastroenterology. 2002; 5:17-22.
  329. Shah V. Portal hypertension and the hyperdynamic circulation: nitric oxide in a haze of cannabinoid smoke. Hepatology. 2001 Nov; 34(5):1060-1.
    View PubMed
  330. Menon KV, Gores GJ, Shah VH. Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc. 2001 Oct; 76 (10):1021-9
    View PubMed
  331. Shah V, Shah V. Cellular and molecular basis of portal hypertension. Clin Liver Dis. 2001 Aug; 5 (3):629-44
    View PubMed
  332. Shah V, Cao S, Hendrickson H, Yao J, Katusic ZS. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol Gastrointest Liver Physiol. 2001 Jun; 280 (6):G1209-16
    View PubMed
  333. Cao S, Yao J, McCabe TJ, Yao Q, Katusic ZS, Sessa WC, Shah V. Direct interaction between endothelial nitric-oxide synthase and dynamin-2. Implications for nitric-oxide synthase function. J Biol Chem. 2001 Apr 27; 276 (17):14249-56 Epub 2000 Dec 18
    View PubMed
  334. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, Katusic ZS. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol. 2000 Dec; 279 (6):R1949-55
    View PubMed
  335. Shah V, Chen AF, Cao S, Hendrickson H, Weiler D, Smith L, Yao J, Katusic ZS. Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro. Am J Physiol Gastrointest Liver Physiol. 2000 Nov; 279 (5):G1023-30
    View PubMed
  336. Khurana VG, Feterik K, Springett MJ, Eguchi D, Shah V, Katusic ZS. Functional interdependence and colocalization of endothelial nitric oxide synthase and heat shock protein 90 in cerebral arteries. J Cereb Blood Flow Metab. 2000 Nov; 20(11):1563-70.
    View PubMed
  337. Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Groszmann RJ, Sessa WC. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am J Physiol Gastrointest Liver Physiol. 1999 Aug 1; 277 (2):G463-G468
    View PubMed
  338. Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Groszmann RJ, Sessa WC. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am J Physiol. 1999 Aug; 277(2 Pt 1):G463-8.
    View PubMed
  339. Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol. 1999; 276:G1043-51.
    View PubMed
  340. Shah V, Toruner M, Haddad F, Cadelina G, Papapetropoulos A, Sessa WC, Groszmann RJ. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental liver cirrhosis. Gastroenterology. 1999; 117:1222-8.
    View PubMed
  341. Shah V, Garcia-Cardena G, Sessa WC, Groszmann RJ. The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology. 1998 Jan; 27(1):279-88.
    View PubMed
  342. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC. Dynamic activation of eNOS synthase by Hsp90. Nature. 1998; 392:821-4.
    View PubMed
  343. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, Sessa WC. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest. 1997 Dec 1; 100(11):2923-30.
    View PubMed
  344. Shah V, Friedman AL, Navarro VJ. Immunology of liver transplantation: clinical management aspects. Gastroenterologist. 1997 Jun; 5(2):137-47.
    View PubMed
  345. Shah V, Waltenbaugh C, Yeldandi A. Peroxisome proliferators increase ethanol metabolism through utilization of the catalase pathway. Int J Oncol. 1997; 11:255-259.
  346. Atucha NM, Shah V, Garcia-Cardena G, Sessa WE, Groszmann RJ. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology. 1996 Dec; 111(6):1627-32.
    View PubMed
  347. Shah V, Marino C, Altice FL. Albendazole-induced pseudomembranous colitis. Am J Gastroenterol. 1996 Jul; 91(7):1453-4.
    View PubMed
  348. Shah V, Webster S, Gottstein J, Blei AT. Reduction of cerebral perfusion precedes rise of intracranial pressure in rats with ischemic fulminant liver failure. Hepatology. 1993 Jun; 17(6):1117-22.
    View PubMed
  349. Jacob P, Kahrilas PJ, Logemann JA, Shah V, Ha T. Upper esophageal sphincter opening and modulation during swallowing. Gastroenterology. 1989 Dec; 97(6):1469-78.
    View PubMed
PST-20221153